SCHEDULE 13D/A Filed 2026-07-20 Event 2026-07-16 SEC 0001213900-26-079584 →

L.I.A. Pure Capital Ltd → Evogene Ltd. EVGN

Stake: — Shares: 2,228,100 Class: Ordinary shares, par value NIS 0.20 per share and American Depositary Shares, each representing one (1) Ordinary Share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

2 13D/G filings on this issuer

1 other filing besides this one

Filer Track Record

10 filings by this filer

9 other filings in the data moat

Short Interest · settle 2026-06-30

DTC 1.00

207,368 shares short · -33.9% vs prior

Other 13D/G Filings on Evogene Ltd.

Filed	Form	Filer	Stake	Shares
2026-07-10	SCHEDULE 13D	L.I.A. Pure Capital Ltd	12.61%	1,526,100	view →

Other Filings by L.I.A. Pure Capital Ltd

Filed	Form	Issuer	Stake	Shares
2026-07-10	SCHEDULE 13D	Evogene Ltd. EVGN	12.61%	1,526,100	view →
2025-06-04	SCHEDULE	XYLO TECHNOLOGIES LTD	5.66%	2,900,000	view →
2020-12-03	SC	Therapix Biosciences Ltd. SPRC	—	—	view →
2020-07-01	SC	Therapix Biosciences Ltd. SPRC	—	—	view →
2020-06-26	SC	Therapix Biosciences Ltd. SPRC	—	—	view →
2020-06-09	SC	Medigus Ltd.	—	—	view →
2020-06-09	SC	Therapix Biosciences Ltd. SPRC	—	—	view →
2020-04-28	SC	Medigus Ltd.	—	—	view →
2019-03-18	SC	BOS BETTER ONLINE SOLUTIONS LTD BOSC	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →